Precision Therapeutics Inc. (AIPT) At $0.99 Forms Bottom; 12 Bullish Analysts Covering Britvic plc (LON:BVIC)

May 16, 2018 - By Henry Gaston

Britvic plc (LON:BVIC) Logo

Precision Therapeutics Inc. (AIPT) formed multiple bottom with $0.96 target or 3.00% below today’s $0.99 share price. Precision Therapeutics Inc. (AIPT) has $11.66 million valuation. The stock increased 1.86% or $0.018 during the last trading session, reaching $0.988. About 101,788 shares traded. Precision Therapeutics Inc. (NASDAQ:AIPT) has declined 45.89% since May 16, 2017 and is downtrending. It has underperformed by 57.44% the S&P500.




Among 18 analysts covering Britvic PLC (LON:BVIC), 12 have Buy rating, 1 Sell and 5 Hold. Therefore 67% are positive. Britvic PLC had 203 analyst reports since July 23, 2015 according to SRatingsIntel. The stock of Britvic plc (LON:BVIC) has “Hold” rating given on Thursday, May 10 by Numis Securities. JP Morgan maintained Britvic plc (LON:BVIC) rating on Monday, September 19. JP Morgan has “Underweight” rating and GBX 590 target. The firm has “Overweight” rating given on Thursday, December 1 by Barclays Capital. The company was maintained on Thursday, August 11 by Goodbody. As per Thursday, October 22, the company rating was maintained by Deutsche Bank. The stock has “Underweight” rating by JP Morgan on Monday, September 12. The company was maintained on Thursday, May 25 by Barclays Capital. The stock has “Hold” rating by Investec on Monday, July 27. As per Wednesday, April 20, the company rating was maintained by JP Morgan. Numis Securities maintained the stock with “Buy” rating in Tuesday, January 5 report. See Britvic plc (LON:BVIC) latest ratings:

10/05/2018 Broker: Numis Securities Rating: Hold Old Target: GBX 785.00 Maintain
01/05/2018 Broker: JP Morgan Rating: Overweight New Target: GBX 810.00 Maintain
23/04/2018 Broker: Citigroup Rating: Buy Old Target: GBX 870.00 New Target: GBX 870.00 Maintain
06/04/2018 Broker: JP Morgan Rating: Overweight Old Target: GBX 870.00 New Target: GBX 810.00 Upgrade
08/03/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 680.00 New Target: GBX 870.00 Upgrade
07/02/2018 Broker: Goldman Sachs Rating: Neutral Old Target: GBX 760.00 New Target: GBX 765.00 Maintain
02/02/2018 Broker: Jefferies Rating: Hold Old Target: GBX 800.00 New Target: GBX 780.00 Maintain
01/02/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 810.00 New Target: GBX 810.00 Maintain
31/01/2018 Broker: Numis Securities Rating: Hold Old Target: GBX 785.00 New Target: GBX 785.00 Maintain
31/01/2018 Broker: Shore Capital Rating: Sell Maintain

The stock decreased 0.77% or GBX 5.75 during the last trading session, reaching GBX 744.25. About 75,706 shares traded. Britvic plc (LON:BVIC) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Britvic plc, together with its subsidiaries, makes, markets, and distributes soft drinks primarily in the United Kingdom, the Republic of Ireland, France, and Brazil. The company has market cap of 1.96 billion GBP. It offers soft drinks comprising sparkling sodas, juice drinks, ice tea, squash, syrups, mineral water, mixers, energy drinks, liquid concentrates, and ready-to-drink nectar drinks under the 7Up, Ballygowan, Britvic, C&C, Club Mixers, Club Orange, DaFruta, Drench, Energise Sport, Fruit Shoot, Gatorade, J2O, Lipton, Maguary, MiWadi, Mountain Dew, Pepsi Max, Purdey's, R Whites, Robinsons, Squash'd, Tango, Teisseire, and TK, as well as Britvic Mixers, Juices, and Cordials brands. It has a 17.64 P/E ratio. The firm also supplies water-coolers and bottled water; engages in the wholesale of soft drinks to the licensed trade; and offers financing services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts